Caris Life Sciences Inc. (CAI)
NASDAQ: CAI
· Real-Time Price · USD
31.78
2.07 (6.97%)
At close: Oct 03, 2025, 3:59 PM
31.74
-0.13%
After-hours: Oct 03, 2025, 07:51 PM EDT
6.97% (1D)
| Bid | 28.78 |
| Market Cap | 8.94B |
| Revenue (ttm) | 483.04M |
| Net Income (ttm) | -351.58M |
| EPS (ttm) | -3.94 |
| PE Ratio (ttm) | -8.07 |
| Forward PE | 106.11 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 38.2 |
| Volume | 642,271 |
| Avg. Volume (20D) | 663,249 |
| Open | 29.61 |
| Previous Close | 29.71 |
| Day's Range | 29.56 - 31.89 |
| 52-Week Range | 25.40 - 42.50 |
| Beta | n/a |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for CAI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+5.61%
Caris Life Sciences shares are trading higher afte...
Unlock content with
Pro Subscription
2 months ago
+7.07%
Caris Life Sciences shares are trading higher after the company announced it will publish recent findings regarding tumor-infiltrating clonal hematopoiesis in the New England Journal of Medicine.
